The Hon. (Mrs.) Chamindranee Kiriella, Attorney-at-Law

Samagi Jana Balawegaya· Mahanuwara· 24 July 2025 ·Oral question: Oral Question: Apeksha Hospital Treatment and Medicines (Q.1)

HealthcareEmployment

AI summary generated by gpt-5.5

The member questioned the Government’s commitment to prioritizing local manufacturers, noting that 60–70 per cent of required medicines are still imported. She asked what steps would be taken to address delays in NMRA registrations affecting local pharmaceutical manufacturers, including delays that hinder export registration.

Verbatim record (translated)

Machine-translated from Sinhala / Tamil / English

¶ 01 This Government promised priority to local manufacturers. Yet 60-70% of needed medicines are imported. Many local manufacturers face delays in registration at the NMRA, which also affects export registrations. What steps will you take?

Provenance

Source: Hansard, Thursday, 24 July 2025 ·No. 1754026625097211 ·English daily/uncorrected Hansard
Page · column: not yet extracted — page/column anchors are not in the current dataset; the source PDF is the citable location.
Permalink: /lk/speeches/18472

View source PDF ↗ Suggest a correction

Cite as: The Hon. (Mrs.) Chamindranee Kiriella, Attorney-at-Law. 10th Parliament, Parliament of Sri Lanka. Hansard, 24 July 2025. No. 1754026625097211. Politick, https://staging.politick.io/lk/speeches/18472